Press releases

December 27, 2024

October 7, 2024

賽諾菲針對商標名稱遭盜用販售「使蒂諾斯Stilnox」之聲明

February 29, 2024

Sanofi International Rare Diseases Day Press Release

November 15, 2023

糖尿病照護邁入數位時代賽諾菲攜手智抗糖胰島素管理數位療法獲SaMD認證

July 20, 2023

賽諾菲加速創新放眼2030年疫苗年銷售額可望逾100億歐元

April 26, 2023

罕病龐貝氏症治療照護進階賽諾菲攜手病友、專家與法國工商會同慶

October 8, 2023

深耕台灣四十年台灣賽諾菲獲金商獎優良外商

June 15, 2022

賽諾菲-葛蘭素史克次世代COVID-19 追加劑展現對變異病毒株(含Omnicron)的強大免疫反應

April 29, 2022

新冠來襲流感反撲疫苗選擇差很大

February 24, 2022

在抗疫行列挺身而出新冠疫苗追加劑新添生力軍賽諾菲與葛蘭素史克重組蛋白疫苗將提交審核

February 9, 2021

跨國藥廠賽諾菲推出全新品牌識別凝聚信念致力創新為病患帶來更多福祉

April 16, 2019

跨國藥廠賽諾菲宣布成立非營利事業部

July 13, 2020

賽諾菲：Plaquenil® 必賴克瘻膜衣錠與COVID-19相關重要資訊

June 18, 2019

Sanofi and Google to develop new healthcare Innovation Lab

June 7, 2019

Paul Hudson to succeed Olivier Brandicourt as Chief Executive Officer

April 18, 2019

賽諾菲捐款近三億五千萬台幣助重建巴黎聖母院